Vima Therapeutics
Clinical trials sponsored by Vima Therapeutics, explained in plain language.
-
New hope for dystonia: experimental drug VIM0423 enters key trial
Symptom relief Recruiting nowThis study tests whether an experimental drug called VIM0423 can reduce muscle spasms and improve daily life for people with isolated dystonia, a movement disorder. About 100 adults aged 18 to 65 with dystonia affecting at least two body areas will receive either the drug or a pl…
Phase: PHASE2 • Sponsor: Vima Therapeutics • Aim: Symptom relief
Last updated May 26, 2026 05:28 UTC
-
Dystonia study seeks to uncover hidden toll of movement disorder
Knowledge-focused Recruiting nowThis study watches how dystonia (a condition causing muscle spasms) changes over time in 200 people aged 12-65. Researchers will track symptoms, pain, and daily challenges using standard rating scales. No experimental treatment is given—the goal is simply to better understand the…
Sponsor: Vima Therapeutics • Aim: Knowledge-focused
Last updated May 19, 2026 11:59 UTC